High rates of failure, exorbitant costs, and the sluggish pace of new drug discovery and
development have led to a growing interest in repurposing “old” drugs to treat both common …

Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

The emergence of nanomedicine drugs as a result of the fast advancement of
nanotechnology offers enormous potential for improving cancer treatment strategies. The …

Liposomal delivery systems have significantly enhanced the efficacy and safety of
chemotherapeutic agents compared to free (non-liposomal) formulations. Liposomes are …

Resveratrol (RES), a natural polyphenol in fruits, has shown promising anti-cancer
properties. Due to its relative low toxicity which limits the adverse effects observed for …

Lung cancer (LC) is one of the leading causes of mortality accounting for almost 25% of
cancer deaths throughout the world. The shortfall of affordable and effective first-line …

Albumin is derived from plasma and it is the most abundant protein in plasma, which is an
ideal material for the preparation of nanoparticles because of its good biocompatibility …

With the advancement of nanotechnology, many different forms of nanoparticles (NPs) are
created, which specifically enhance anticancer drug delivery to tumour cells. Albumin bio …

Non-small cell lung cancer (NSCLC) is a global concern as one of the leading causes of
cancer deaths. The treatment options for NSCLC are limited to systemic chemotherapy …

A photocatalyzed cascade double C–C formation via sp2 C–H bond activation of
diarylamines with hypervalent iodine diazo reagents was developed. A variety of …